You are here: Industry Insights > china

News List

Comparison of Improved New Drugs Paths between China and the United States and Analysis of R&D Status in China Kevin
April 28, 2025
This article describes successful practices from the United States 505(b)(2) pathway and analyzes R&D status of China's modified new drugs.
A Decade of Transformation in China's Innovative Drug Industry: The Journey from Follower to Leader Kevin
March 14, 2025
Over the past decade, China's innovative drug market has experienced remarkable transformation and growth. With the combined drive of policies, technology, and capital, China's innovative drug industry has entered a golden period of growth. This paper pro
A Record High! A Review of Blockbuster New Drugs in China in 2024, with the Number of Innovative Drugs Reaching New Heights! Sophia
January 23, 2025
In 2024, China's pharmaceutical field thrived. NMPA approved 220 new drugs, including 46 Class 1 innovative ones with anti-tumor drugs being the most. New anti-tumor drugs offered hope, and the R&D environment will keep improving.
China's Innovative Drugs Hunt for Billion Dollar Molecule Xiaobin
December 20, 2024
The Central Economic Work Conference in 2023 emphasized the need to promote industrial innovation through, especially by fostering new industries, new models, and new growth engines and developing new forms of productive forces.
20 Years of Growth and Innovation in China, Fette Compacting Launches F30p Tablet Press PharmaSources
December 13, 2024
Interview Dr. Andreas Risch——Managing Director of Fette Compacting (China) Co., Ltd.
Echinacea Extract: Therapeutic Potential and Traditional Uses David Orchard-Webb
November 05, 2024
Echinacea is known for its brilliant purple petals and cone-shaped core, has been used for generations for medicinal purposes.
Where Lies the Competitiveness of China's New Drugs for Central Nervous System? Prof. Zhang
October 18, 2024
The Global Challenges and Opportunities of the R&D of New Drugs for Central Nervous System
Ulinastatin in Japan, China, and India David Orchard-Webb
October 09, 2024
Ulinastatin, a naturally occurring protease modulator generated from human urine, has been used for decades to treat inflammatory disorders like sepsis, acute pancreatitis, and organ failure.
Broad-spectrum anti-cancer drug "returns" to China, and the market landscape has already changed drastically Yefenghong
May 27, 2024
Paclitaxel, a natural product extracted from taxus chinensis, acts on the microtubule to inhibit the mitosis of tumor cells and is one of the most important broad-spectrum chemotherapy drugs.
Tris Base Manufacturers in China PharmaSources
May 13, 2024
Tris base, also known as Tris(hydroxymethyl)aminomethane, is a commonly used biological buffer in biochemical and molecular biology laboratories.